Research Article
The Role of Parathyroid Hormone and Vitamin D Serum Concentrations in Patients with Cardiovascular Diseases
Table 1
Patient characteristic divided depending on heart failure occurrence.
| | HF present () | HF absent () | |
| Age | 61.5 (57.0–74.0) | 65.3 (57.0–74.0) | ns | Male (%) | 36 (72) | 43 (56) | ns | BMI | 28.1 (24.3–30.9) | 28.5 (25.4–31.2) | ns | Hypertension | 38 (76) | 61 (79) | ns | Dyslipidemia | 32 (64) | 38 (49) | ns | Diabetes | 15 (30) | 27 (35) | ns | Atrial fibrillation | 14 (28) | 8 (10) | 0.02 | Urgent admission | 22 (44) | 34 (44) | ns | Sun exposure >7 h/week | 26 (52) | 50 (65) | ns | Coronary artery disease | 39 (78) | 59 (77) | ns | EDV (ml) | 146.2 ± 55.9 | 86.3 ± 20.9 | 0.001 | LVEF (%) | 28.7 ± 11.7 | 55.9 ± 4.7 | 0.001 | ICD | 12 (24) | 1 (1) | 0.001 | CRT | 2 (4) | 0 (0) | ns | DDDR | 2 (4) | 13 (17) | 0.06 | VVIR | 2 (4) | 5 (5) | ns | OHT | 2 (4) | 0 (0) | ns | DEATH (during hospitalization) | 2 (4) | 2 (3) | ns |
|
|
HF: heart failure; BMI: body mass index; >7 h/week: more than seven hours per week; EDV: end-diastolic volume; LVEF: left ventricular ejection fraction; ICD: implantable cardioverter-defibrillator; CRT: cardiac resynchronization therapy; DDDR: dual chamber permanent pacemaker; VVIR: single chamber permanent pacemaker; OHT: orthotopic heart transplantation.
|